Mackenzie Lane Morrison, PHARMD is a
Pharmacist based in Gallatin, Missouri. Mackenzie Lane Morrison is licensed to practice in Missouri (license number 2008027918) and her current practice location is
403 S Main St, Gallatin, Missouri. She can be reached at her office (for appointments etc.) via phone at
(660) 663-7979.
NPI number for Mackenzie Lane Morrison is 1851917850 and her current mailing address is 403 S Main St, Gallatin, Missouri. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1851917850.
Healthcare Provider's Profile
Full Name | Mackenzie Lane Morrison |
---|
Gender | Female |
---|
Speciality | Pharmacist |
---|
Location | 403 S Main St, Gallatin, Missouri |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1851917850
- Provider Enumeration Date: 06/25/2020
- Last Update Date: 06/25/2020
Medical Identifiers
Medical identifiers for Mackenzie Lane Morrison such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1851917850 | NPI | - | NPPES |
2008027918 | Other | MO | MISSOURI BOARD OF PHARMACY PHARMACIST LICENSE |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
183500000X | Pharmacist | 2008027918 (Missouri) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mackenzie Lane Morrison is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Mackenzie Lane Morrison, PHARMD 403 S Main St, Gallatin, MO 64640-1434 Ph: (660) 663-7979 | Mackenzie Lane Morrison, PHARMD 403 S Main St, Gallatin, MO 64640-1434 Ph: (660) 663-7979 |
Reviews and Comments